Diastolic RV EvAluation with Millar catheter to investigate the effect of Glucagon-Like Peptide-1 (GLP-1) on right ventricular function during elective coronary angioplasty and stenting

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN03253693

Enrollment

Registered

2014-10-22

Start date

2014-09-22

Completion date

Unknown

Last updated

2019-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Cardiovascular disease

Interventions

GLP-1, GLP-1

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age over 18 2. Able to give informed consent 3. Elective percutaneous intervention for a single vessel right coronary artery stenosis >75% 4. Normal right ventricular function

Exclusion criteria

Exclusion criteria: 1. Severe comorbidity expected life (<6months) 2. Nicorandil or a GLP1 receptor agonist or DPP4 inhibitor use 3. Women of child bearing age 4. Myocardial infarction within the previous 3 months 5. Previous coronary artery bypass graft to the RCA 6. Significant known left to right shunt 7. Permanent pacemaker 8. Atrial fibrillation

Design outcomes

Primary

Measure	Time frame
Improvement in RV diastolic dysfunction	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026